Stay updated with breaking news from Peripheral Interventions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Today, Boston Scientific (NYSE: BSX) announced positive results for the EkoSonic™ Endovascular System (EKOS system) during a late-breaking...
/PRNewswire/ -- Today, Boston Scientific (NYSE: BSX) announced positive results for the EkoSonic™ Endovascular System (EKOS system) during a late-breaking...
NICE RECOMMENDS BOSTON SCIENTIFIC THERASPHERE ™ LONDON, UK (26 February 2021) –The National Institute for Health and Care Excellence (NICE) has issued guidance recommending the use of TheraSphere ™ Y-90 Glass Microspheres for the treatment of patients with hepatocellular carcinoma (HCC), the most common form of liver cancer with more than 6,400 cases diagnosed annually, through the NHS in England, Wales and Northern Ireland. 1 The outcomes of more than 100 clinical studies demonstrate the effectiveness of TheraSphere in improving tumour response across all stages of liver cancer, ...
Operator Good morning, and welcome to the Boston Scientific Fourth Quarter 2020 Financial Results Conference Call. [Operator Instructions] I would now like to turn the conference over to Susan Lisa, Vice President, Investor Relations. Please go ahead. Susie Lisa -- Vice President, Investor Relations Thank you, Andrew. Good morning, everyone, and thanks for joining us. With me on today's call are Mike Mahoney, Chairman and Chief Executive Officer and Dan Brennan, Executive Vice President and Chief Financial Officer. We issued a press release earlier this morning announcing our Q4 2020 results...
/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales, based upon preliminary unaudited financial information, of approximately $2.71...